Barclays PLC Acquires 62,354 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

Barclays PLC lifted its holdings in Definitive Healthcare Corp. (NASDAQ:DH) by 318.8% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 81,916 shares of the company’s stock after acquiring an additional 62,354 shares during the quarter. Barclays PLC owned 0.07% of Definitive Healthcare worth $366,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Point72 DIFC Ltd raised its holdings in Definitive Healthcare by 759.9% during the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock valued at $42,000 after buying an additional 8,215 shares during the last quarter. Intech Investment Management LLC bought a new stake in Definitive Healthcare during the 3rd quarter valued at $55,000. Bleakley Financial Group LLC bought a new stake in Definitive Healthcare during the 3rd quarter valued at $74,000. Glenmede Trust Co. NA raised its holdings in Definitive Healthcare by 41.1% during the 3rd quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock valued at $82,000 after buying an additional 5,362 shares during the last quarter. Finally, SG Americas Securities LLC bought a new stake in Definitive Healthcare during the 3rd quarter valued at $84,000. 98.67% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Definitive Healthcare

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total transaction of $211,500.00. Following the transaction, the insider now owns 433,830 shares in the company, valued at approximately $2,039,001. This represents a 9.40 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 14.84% of the company’s stock.

Definitive Healthcare Price Performance

DH opened at $4.36 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The stock has a market capitalization of $503.68 million, a P/E ratio of -1.41, a P/E/G ratio of 3.29 and a beta of 1.40. The company’s 50-day simple moving average is $4.37 and its two-hundred day simple moving average is $4.58. Definitive Healthcare Corp. has a 52-week low of $3.19 and a 52-week high of $10.62.

Analyst Ratings Changes

A number of equities research analysts recently commented on DH shares. BTIG Research began coverage on shares of Definitive Healthcare in a report on Tuesday, September 17th. They set a “buy” rating and a $7.00 price target for the company. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a report on Friday, November 8th. Finally, Stephens began coverage on shares of Definitive Healthcare in a report on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price objective for the company. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $5.72.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.